Q2 2017 Hemispherx Biopharma Inc Earnings Call

15/8/2017 13:00

Conference Call Hemispherx Biopharma Inc

Hemispherx Biopharma Inc Conference call or earnings call will be held on Aug 15, 2017 During the earnings conference call's session Hemispherx Biopharma Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact Hemispherx Biopharma Inc for this information
Schedule a conference call with QCONF and get 5 free conference calls.
Hemispherx Biopharma, Inc. and its subsidiaries (collectively, "Hemispherx", "Company", "we" or "us") are a specialty pharmaceutical company headquartered in Philadelphia, Pennsylvania and engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. We were first formed in 1966 and in the early 1970s were doing contract research for the National Institutes of Health. Since that time, we have established a strong foundation of laboratory, pre-clinical and clinical data with respect to the development of natural interferon and nucleic acids to enhance the natural antiviral defense system of the human body and to aid the development of therapeutic products for the treatment of certain chronic diseases. We have two domestic subsidiaries BioPro Corp., and BioAegean Corp., all of which are incorporated in Delaware and are dormant.    
Read more Conference Call

Hemispherx Biopharma Inc (HEB)

One Penn Center, Philadelphia Pennsylvania 19103, United States